Found: 14
Select item for more details and to access through your institution.
T-Cell Receptor V<sub>β</sub> Spectrotypes of Central Nervous System T-Cells during Acute Relapsing Experimental Autoimmune Disease.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 756, n. 1, p. 327, doi. 10.1111/j.1749-6632.1995.tb44535.x
- By:
- Publication type:
- Article
Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma.
- Published in:
- 2002
- By:
- Publication type:
- Case Study
The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor–recipient pairs.
- Published in:
- Bone Marrow Transplantation, 2000, v. 25, n. 4, p. 385, doi. 10.1038/sj.bmt.1702161
- By:
- Publication type:
- Article
Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
- Published in:
- Bone Marrow Transplantation, 1997, v. 19, n. 10, p. 1001, doi. 10.1038/sj.bmt.1700779
- By:
- Publication type:
- Article
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 9, p. 1176, doi. 10.1038/bmt.2014.122
- By:
- Publication type:
- Article
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 7, p. 913, doi. 10.1038/bmt.2014.84
- By:
- Publication type:
- Article
Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34<sup>+</sup> cells and a fixed CD3<sup>+</sup> dose.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 4, p. 508, doi. 10.1038/bmt.2012.186
- By:
- Publication type:
- Article
The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 1, p. 19, doi. 10.1038/bmt.2012.105
- By:
- Publication type:
- Article
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 6, p. 790, doi. 10.1038/bmt.2010.209
- By:
- Publication type:
- Article
Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions.
- Published in:
- Bone Marrow Transplantation, 2009, v. 44, n. 12, p. 805, doi. 10.1038/bmt.2009.87
- By:
- Publication type:
- Article
Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies.
- Published in:
- Bone Marrow Transplantation, 2009, v. 43, n. 6, p. 469, doi. 10.1038/bmt.2008.339
- By:
- Publication type:
- Article
Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders.
- Published in:
- Bone Marrow Transplantation, 2008, v. 42, n. 2, p. 83, doi. 10.1038/bmt.2008.89
- By:
- Publication type:
- Article
Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
- Published in:
- Bone Marrow Transplantation, 2007, v. 40, n. 7, p. 621, doi. 10.1038/sj.bmt.1705785
- By:
- Publication type:
- Article
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.
- Published in:
- Bone Marrow Transplantation, 2006, v. 37, n. 3, p. 263, doi. 10.1038/sj.bmt.1705240
- By:
- Publication type:
- Article